The MicroStent HEAL Registry: Interim 6-Month Outcomes
One third of peripheral arterial disease (PAD) patients will advance to critical limb ischemia (CLI)/ chronic limb-threatening ischemia (CLTI), and end-stage disease progression, characterized by rest pain, tissue loss, gangrene, and amputation. Despite ameliorative progress, percutaneous transluminal angioplasty clinical outcomes remain suboptimal. There is still a lack of solutions to improve patency. The HEAL registry collects outcomes data for the treatment of predominantly CLI/CLTI patients implanted with the MicroStent, designed specifically for below-the-knee (BTK) intervention. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Marco Manzi, Koen R. Deloose, Andrej Schmidt, Dierk Scheinert, Thomas Zeller, Lieven Maene, Daniel van den Heuvel, Wouter Lansink, Luis Mariano Palena, Paolo Sbarzaglia, Marianne Brodmann, Michael Lichtenberg Source Type: research
Sex-Related Differences and Factors Associated With Peri-Procedural and 1-Year Mortality in Chronic Limb-Threatening Ischemia Patients From the CLIMATE Italian Registry
Martelli E, Zamboni M, Sotgiu G, et al. Sex-Related Differences and Factors Associated with Peri-Procedural and 1 Year Mortality in Chronic Limb-Threatening Ischemia Patients from the CLIMATE Italian Registry. J Pers Med. 2023;13(2):316. doi: 10.3390/jpm13020316. PMID: 36836550; PMCID: PMC9959358. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Eugenio Martelli, Matilde Zamboni, Giovanni Sotgiu, Laura Saderi, Massimo Federici, Giuseppe M. Sangiorgi, Mariangela Puci, Allegra Rosa Martelli, Teresa Messina Source Type: research
Evaluation of Safety and Effectiveness of Treatment for Iliac Artery Stenosis Using Percutaneous Radial or Brachial Access – The IRBIS Registry
Endovascular repair of iliac artery stenosis/occlusion is usually performed through femoral access. This access is relatively easy for the surgeon, but can be problematic in cases of calcification in the common femoral arteries, obesity, or previous arterial punctures. Also, complications associated with femoral access can be much more severe than when treatment is performed using radial or brachial access. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Przemyslaw Nowakowski Source Type: research
Severe Intermittent Claudication. Medical Treatment or Primary Percutaneous Intervention?
The objective of this study was to demonstrate that medical treatment is useful in improving severe intermittent claudication (Rutherford 3/Fontaine IIB) in patients with peripheral vascular disease, without primary percutaneous interventions. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Juan I. Pardo, Daniel Paliza, Lisandro Carnero, Sergio Palomeque, Ana Mollon Source Type: research
Long-Term Outcomes of Endovascular Femoropopliteal Therapy With and Without Atherectomy for Lower Extremity Arterial Ulcers
Atherectomy for the treatment for peripheral artery disease (PAD) is increasingly utilized in practice. Although the use of atherectomy has increased in the United States, there is still limited data showing its efficacy and durability compared to angioplasty and stenting alone. Our objective was to analyze long-term outcomes in patients suffering from arterial lower extremity ulcers with and without diabetes who underwent endovascular treatment for femoropopliteal disease (with and without atherectomy). (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Neil A. Patel, Rahman Sayed, Evan Lipsitz, James Hu, Shuo Huang, Jeffrey Indes Source Type: research
Revascularization of Target Artery Path is a Substantial Way for Salvage of Critical Limb Ischemia
The ‘Angiosomal map’ was a fictitious theory revealed during anatomical studies that was used for surgical planning in reconstruction procedures. Target arterial pathway (TAP) determines how tissue fed with a specific direct arterial flow can significantly affect wound healing and limb rescue. Defin ing the new term has helped provide new information that could be applicable to improve revascularization of ischemic tissue lesions. The concept allows for intentional arterial reconstruction with priorities in specific ischemic regions. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Ahmed Y. Sakr, Mahmoud Salah, Alaa Eldin Ahmed, Farouk El Alfy, Yehia Alfarra Source Type: research
The Impact of Open Versus Endovascular Procedure Choice on Arterial Thrombosis in Peripheral Artery Disease
This study aimed to determine if open versus endovascular revascularization procedure choice impacts thrombotic rates in peripheral arterial disease (PAD) patients. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Shiv Patel Source Type: research
The Quantitative Impact of Warfarin Versus Factor Xa Inhibitors on Anticoagulation Profiles in Patients With Peripheral Artery Disease Post-Revascularization
Anticoagulants are a mainstay of thromboembolic prevention in patients with cardiovascular disease, including peripheral artery disease (PAD). Newer factor Xa inhibitors are now being widely used in place of warfarin. There is a paucity of data regarding the impact of type of anticoagulant on coagulation parameters. The aim of this study was to quantify differences in coagulation parameters in patients taking warfarin versus factor Xa inhibitors. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Sasha Suarez Ferreira, Ryan Hall, Katherine Morrow, Shiv Patel, Ivy Lee, Fanah Hagos, Nikolaos Zacharias, Kellie Machlus, Anahita Dua Source Type: research
Deep Venous Arterialization – The Australian Experience
Chronic limb threatening ischemia (CLTI) represents the end-stage of peripheral arterial disease (PAD). It is characterized by ischemic rest pain and tissue loss. It causes significant morbidity, with over 20% of affected patients having major limb amputations, which itself has public health implications. Treatment of CLTI is nuanced, with the development of complex revascularisation techniques. However, there ’s a subset of patients that have no distal arterial targets for reconstruction, or severe infra-malleolar disease that cannot be revascularized. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Kevin Tian, Victoria White, Ramesh Velu Source Type: research
An Open-Label First-in-Man Usability and Safety Investigation With an Intravenous Injection Technique to Deploy Tumescence During Laser Ablation of the Great Saphenous Vein
The standard method for the treatment of varicose veins is an endothermal technique, aiming to accomplish long-term vein obliteration. However, one issue is the need for tumescence. Currently, tumescence is delivered via numerous injections through the skin during ultrasound guidance, therefore requiring considerable training to achieve acceptable results. Even then, patients may find the procedure painful, and may need supplementary sedation. The aim of this prospective feasibility study was to assess patient safety and comfort using the Solutio ™ system. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Michael Akesson, Anders Lundell Source Type: research
Endovenous Laser Ablation of Incompetent Anterior Accessory Saphenous Veins of Different Anatomical Patterns Using Bare-Tip Fibers: A Case Series
To demonstrate the feasibility and technical success of endovenous laser ablation (EVLA) for incompetent anterior accessory saphenous veins (AASV) of different anatomical patterns using bare-tip fibers. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Artur Avetisyan Source Type: research
Iliocaval Occlusion – Endovascular Approach With IVUS and Cone Beam Computed Tomography
Iliocaval occlusions can be severely disabling, having an impact on patients ’ daily activities. With the improvement of dedicated venous stents, and the evolution of the technique, the endovascular approach is now considered the best option. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Nelson Camacho, S érgio Silva Source Type: research
The Role of Short-term IVC Filter Placement in Patients With High-risk DVT
Inferior vena cava (IVC) interruption is widely accepted to help prevent pulmonary emboli (PE) in patients with deep venous thrombosis (DVT) who cannot receive anticoagulation (AC), but not in those who can receive AC as the primary treatment. There is an area of uncertainty in patients who have a short-term contraindication to AC, who may benefit from a temporary IVC filter. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Patrick Downs, Todd Russell, Kate Gates, Robert Cotterman, Fedor Lurie Source Type: research
Assessing the Necessity of Inferior Vena Cava Filter Insertion in Acute Iliofemoral Deep Vein Thrombosis: A Retrospective Analysis
In cases of acute iliofemoral deep vein thrombosis (IFDVT), there is a recognized benefit in reducing thrombus burden to enhance long-term prognosis and reduce complications, such as post-thrombotic syndrome. Typically, thrombus-reducing interventions involve inferior vena cava (IVC) filter insertion due to the potential risk of pulmonary thromboembolism (PTE) during surgical procedures. However, questions have arisen regarding the necessity of IVC filter insertion in such cases. (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Deokbi Hwang Source Type: research
Six-Month Results of the World's First VASC Clinical Trial for Endovascular NTNT Treatment of GSV Through Empty Vein Ablation Using Velex ™
To report six-month results from the VASC (Vacuum Assisted Sclerotherapy Catheter) study, a multicentric, prospective, non-randomized trial with the primary objective to confirm safety and efficacy of Velex for empty vein ablation (EVA) of the great saphenous vein (GSV; ClinicalTrials.gov, NCT05581524). (Source: Journal of Vascular Surgery)
Source: Journal of Vascular Surgery - March 20, 2024 Category: Surgery Authors: Paolo Righini, Daniela Mazzaccaro, Claudia Cesi, Domenico Baccellieri, Giovanni Nano Source Type: research
